DK0791355T3 - Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi - Google Patents

Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi

Info

Publication number
DK0791355T3
DK0791355T3 DK97200415T DK97200415T DK0791355T3 DK 0791355 T3 DK0791355 T3 DK 0791355T3 DK 97200415 T DK97200415 T DK 97200415T DK 97200415 T DK97200415 T DK 97200415T DK 0791355 T3 DK0791355 T3 DK 0791355T3
Authority
DK
Denmark
Prior art keywords
ischemia
tissue damage
reducing tissue
damage associated
reducing
Prior art date
Application number
DK97200415T
Other languages
English (en)
Inventor
Eric R Pettipher
Thomas A Beyer
Delvin R Knight Jr
Banavara L Mylari
Peter J Oates
Wayne R Tracey
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0791355T3 publication Critical patent/DK0791355T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK97200415T 1996-02-29 1997-02-13 Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi DK0791355T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1270896P 1996-02-29 1996-02-29

Publications (1)

Publication Number Publication Date
DK0791355T3 true DK0791355T3 (da) 2002-06-17

Family

ID=21756305

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97200415T DK0791355T3 (da) 1996-02-29 1997-02-13 Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi

Country Status (15)

Country Link
US (1) US5932581A (da)
EP (1) EP0791355B1 (da)
JP (1) JPH09316004A (da)
KR (1) KR100219972B1 (da)
CN (1) CN1165000A (da)
AT (1) ATE216226T1 (da)
AU (1) AU714038B2 (da)
CA (1) CA2198536C (da)
DE (1) DE69711965T2 (da)
DK (1) DK0791355T3 (da)
ES (1) ES2174176T3 (da)
IL (1) IL120271A (da)
MY (1) MY118982A (da)
PT (1) PT791355E (da)
ZA (1) ZA971715B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2005003199A0 (en) * 1999-04-01 2005-03-31 Pfizer Prod Inc Aminopyrimidines as sorbitol dehydrogenase inhibitors
US6825198B2 (en) * 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
CN104346404B (zh) * 2013-08-08 2018-05-18 华为技术有限公司 一种访问数据的方法、设备及系统

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3905364A1 (de) 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
DE4025387A1 (de) 1990-08-10 1992-02-13 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien
US5728704A (en) 1992-09-28 1998-03-17 Pfizer Inc. Substituted pyridmidines for control of diabetic complications

Also Published As

Publication number Publication date
ES2174176T3 (es) 2002-11-01
ZA971715B (en) 1998-08-27
CA2198536C (en) 2000-06-20
CN1165000A (zh) 1997-11-19
JPH09316004A (ja) 1997-12-09
AU714038B2 (en) 1999-12-16
DE69711965T2 (de) 2003-01-23
CA2198536A1 (en) 1997-08-29
AU1500997A (en) 1997-09-04
ATE216226T1 (de) 2002-05-15
KR100219972B1 (ko) 1999-09-01
DE69711965D1 (de) 2002-05-23
MX9701527A (es) 1998-06-30
PT791355E (pt) 2002-08-30
EP0791355A1 (en) 1997-08-27
IL120271A (en) 2001-06-14
EP0791355B1 (en) 2002-04-17
IL120271A0 (en) 1997-06-10
KR970061257A (ko) 1997-09-12
US5932581A (en) 1999-08-03
MY118982A (en) 2005-02-28

Similar Documents

Publication Publication Date Title
DE69526237D1 (de) Chirurgische gesichtsmaske
BR9707758A (pt) Corpo otico
BR9707766A (pt) Corpo ótico
DE69705401D1 (de) Gesichtsmaske
FI961886L (fi) Ihmisen Kunitz-tyyppiset proteaasi-inhibiittorit
IL120264A0 (en) Method of reducing tissue damage associated with non-cardiac ischemia
NO20010556D0 (no) Fremgangsmåte for oftalmisk administrering
DE69429265D1 (de) Medizinabgabe
NO952977D0 (no) Aminoduhydro-kosopurinyl-metoksypropandiolderivater
DK0764157T3 (da) Benzopyraner og deres anvendelse som terapeutiske midler
DK0791355T3 (da) Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi
DE59400353D1 (de) Am Kopf tragbares Hörgerät
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
EE9400040A (et) Oftalmiliseks otstarbeks mõeldud kompositsioon
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
KR950010913U (ko) 지속형 팬티 기저귀
DK0721781T3 (da) Reduktion af fedtvæv under anvendelse af kollagenase
ES1028186Y (es) Pañuelo monouso.
KR950029532U (ko) 환자용 기저귀
ITPD930207A0 (it) Scacchiera perfezionata
ES1023597Y (es) Vendaje terapeutico perfeccionado.
DE69820049D1 (de) Medizinische Gesichtsmaske
ES1028931Y (es) Estructura perfeccionada para nichos funerarios.
IT229501Y1 (it) Strumento per controllo punteggio ottenuto su schedine totocalcio ad uso diretto del giocatore
NO934049D0 (no) Fremgangsmaate for terapi